Loading insider details...
Beta
Latest Form 4 (Jun 4, 2026): Exercise/Conversion of 89,312 LXRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 89,312 | n/a |
| May 4, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 35,714 | n/a |
| Apr 21, 2026 | AMARIN CORP PLC\UK (AMRN) | Exercise/Conversion | 838 | n/a |
| Jun 3, 2025 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 103,806 | n/a |
| May 13, 2025 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 36,810 | n/a |
| Apr 23, 2025 | AMARIN CORP PLC\UK (AMRN) | Exercise/Conversion | 838 | n/a |
| May 13, 2024 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 44,906 | n/a |
| Apr 19, 2024 | AMARIN CORP PLC\UK (AMRN) | Grant/Award | 179,795 | n/a |
| Jul 31, 2023 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 96,515 | n/a |
| Jul 22, 2023 | AMARIN CORP PLC\UK (AMRN) | Grant/Award | 284,598 | n/a |